Literature DB >> 1636122

Hepatic histopathology in the acquired immunodeficiency syndrome.

N Bach1, N D Theise, F Schaffner.   

Abstract

Involvement of the liver with the same opportunistic organisms and neoplasms affecting other organs has been recognized since the beginning of the AIDS epidemic. In this overview of hepatic histopathologic features in AIDS, we review the range of opportunistic infections and neoplasms accompanying HIV infection. Hepatic disease may result from viral, bacterial, protozoal, or fungal infection, or secondary to drugs and neoplasms. Liver involvement in AIDS usually reflects disseminated rather than primary disease. CMV and mycobacteria are the most common organisms in liver identified in biopsy and autopsy studies. A variety of nonspecific features, including steatosis, granulomas, and sinusoidal abnormalities may also be seen. HIV-1 itself was recently identified in the liver. Speculation regarding the significance of this finding has been discussed in this review. Hepatitis B, C, and D may also complicate the course of disease in patients with AIDS. Hepatitis B behaves differently in the population with AIDS than in immunocompetent patients. We concluded our review with a discussion of the present recommendations regarding the use of liver biopsies in these patients. This topic continues to be widely debated in the literature.

Entities:  

Mesh:

Year:  1992        PMID: 1636122     DOI: 10.1055/s-2007-1007392

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  7 in total

1.  Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

Authors:  E Bierhoff; H P Fischer; E Willsch; J Rockstroh; U Spengler; H H Brackmann; J Oldenburg
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication.

Authors:  Antonella Esposito; Valentina Conti; Maria Cagliuso; Daniele Pastori; Alessandra Fantauzzi; Ivano Mezzaroma
Journal:  AIDS Res Ther       Date:  2011-03-01       Impact factor: 2.250

3.  Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.

Authors:  J S Orange; T P Salazar-Mather; S M Opal; C A Biron
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  HIV-HCV Coinfection.

Authors:  Amrita Sethi; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

Review 5.  Biliary tract pathology in patients with AIDS.

Authors:  R D Goldin; J Hunt
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

6.  Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.

Authors:  I Yust; Z Fox; M Burke; A Johnson; D Turner; A Mocroft; C Katlama; B Ledergerber; P Reiss; O Kirk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-30       Impact factor: 3.267

7.  Use of zidovudine in human immunodeficiency virus-induced hepatitis.

Authors:  D L Wertheim; E Valderamma; V R Bonagura
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.